array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(5) {
[0]=>
array(7) {
["title_en"]=>
string(104) "Elekta to host cancer survivorship event at company’s Learning and Innovation Center (LINC) in Atlanta"
["snippet_en"]=>
string(249) "Atlanta, GA 2015-09-02 Professional BMX athlete Josh Perry to share story of brain tumor treatment with Gamma Knife Elekta, a global cancer management company, will host an educational event on cancer survivorship on September 10, 6:30-8:30 p.m., at"
["url"]=>
string(166) "https://www.elekta.com/press/a3796720-a366-4af0-9922-ef1eb08ef918/elekta-to-host-cancer-survivorship-event-at-company-s-learning-and-innovation-center-linc-in-atlanta"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1639838e-6a84-4394-b4eb-f889799a3563"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2015-09-02"
["categories"]=>
array(2) {
[0]=>
string(5) "Event"
[1]=>
string(27) "Business Model & Innovation"
}
}
[1]=>
array(7) {
["title_en"]=>
string(101) "Elekta Emphasizes Commitment to Safety in Cancer Management at Joint Radiation Physics Annual Meeting"
["snippet_en"]=>
string(246) "ATLANTA and VANCOUVER 2011-07-25 American Association of Physicists in Medicine( AAPM) and Canadian Organization of Medical Physicists( COMP) 2011 combined meeting is forum to showcase breadth of Elekta’ s portfolio Encompassing virtually every"
["url"]=>
string(167) "https://www.elekta.com/press/05a149e8-e56c-4a48-8ff5-760ab17225b7/elekta-emphasizes-commitment-to-safety-in-cancer-management-at-joint-radiation-physics-annual-meeting"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/41a7b1d5-1e55-4848-bd76-f362b9589247"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2011-07-25"
["categories"]=>
array(1) {
[0]=>
string(5) "Event"
}
}
[2]=>
array(7) {
["title_en"]=>
string(62) "Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser"
["snippet_en"]=>
string(247) "Atlanta, GA 2010-09-08 Event to benefit Entertainment Industry Foundation( EIF) cancer programs Elekta is one of the leading supporters of the Rocks Against Cancer benefit to take place September 16 at the Angel Orensanz Foundation for the Arts in"
["url"]=>
string(128) "https://www.elekta.com/press/1b44ec6c-7cb6-44f1-a8c6-33aecc2e1dd3/elekta-among-major-sponsors-of-rocks-against-cancer-fundraiser"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8603ee76-bbe5-4edd-a4f0-4a90ee18edef"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2010-09-08"
["categories"]=>
array(2) {
[0]=>
string(5) "Event"
[1]=>
string(11) "Sponsorship"
}
}
[3]=>
array(7) {
["title_en"]=>
string(67) "Webcast of Presentation by Elekta's CEO Tomas Puusepp on February 6"
["snippet_en"]=>
string(250) "Stockholm 2008-02-04 Webcast of Presentation by Elekta 's CEO Tomas Puusepp on February6 On February6, Tomas Puusepp, President& CEO of Elekta will present at Merrill Lynch Global Pharmaceuticals, Biotechnology& Medical Devices Conference in New York"
["url"]=>
string(133) "https://www.elekta.com/press/bc7ee25d-357e-456f-a3f9-e66691a50699/webcast-of-presentation-by-elekta-s-ceo-tomas-puusepp-on-february-6"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/552c1236-b228-4bbd-aac7-ec1f6359300e"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2008-02-04"
["categories"]=>
array(2) {
[0]=>
string(5) "Event"
[1]=>
string(12) "Board Change"
}
}
[4]=>
array(7) {
["title_en"]=>
string(139) "Elekta to highlight High Definition Dynamic Radiosurgery solutions for faster, more precise stereotactic treatments at ASTRO Annual Meeting"
["snippet_en"]=>
string(249) "BOSTON 2016-09-21 Integrated technology solution enables clinicians to address highly-complex SRS and SBRT treatments with increased confidence At the American Society for Radiation Oncology( ASTRO) Annual Meeting, September 25-28 in Boston, Elekta("
["url"]=>
string(204) "https://www.elekta.com/press/8fad713f-79be-4728-845f-bd69005d3748/elekta-to-highlight-high-definition-dynamic-radiosurgery-solutions-for-faster-more-precise-stereotactic-treatments-at-astro-annual-meeting"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/bf6cbb17-873c-4643-b3e2-cfaed55e708b"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "1928-09-25"
["categories"]=>
array(1) {
[0]=>
string(5) "Event"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
Atlanta, GA 2015-09-02 Professional BMX athlete Josh Perry to share story of brain tumor treatment with Gamma Knife Elekta, a global cancer management company, will host an educational event on cancer survivorship on September 10, 6:30-8:30 p.m., at
ATLANTA and VANCOUVER 2011-07-25 American Association of Physicists in Medicine( AAPM) and Canadian Organization of Medical Physicists( COMP) 2011 combined meeting is forum to showcase breadth of Elekta’ s portfolio Encompassing virtually every
Atlanta, GA 2010-09-08 Event to benefit Entertainment Industry Foundation( EIF) cancer programs Elekta is one of the leading supporters of the Rocks Against Cancer benefit to take place September 16 at the Angel Orensanz Foundation for the Arts in
Stockholm 2008-02-04 Webcast of Presentation by Elekta 's CEO Tomas Puusepp on February6 On February6, Tomas Puusepp, President& CEO of Elekta will present at Merrill Lynch Global Pharmaceuticals, Biotechnology& Medical Devices Conference in New York
BOSTON 2016-09-21 Integrated technology solution enables clinicians to address highly-complex SRS and SBRT treatments with increased confidence At the American Society for Radiation Oncology( ASTRO) Annual Meeting, September 25-28 in Boston, Elekta(
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
